CN Patent
CN101855210A — 用作电压-门控钠通道抑制剂的酰胺类
Assigned to Vertex Pharmaceuticals Inc · Expires 2010-10-06 · 16y expired
What this patent protects
本发明涉及用作电压-门控钠通道抑制剂的化合物。本发明还提供包含本发明化合物的药学可接受的组合物和使用这些组合物治疗各种疾病的方法。
USPTO Abstract
本发明涉及用作电压-门控钠通道抑制剂的化合物。本发明还提供包含本发明化合物的药学可接受的组合物和使用这些组合物治疗各种疾病的方法。
Drugs covered by this patent
- Journavx (SUZETRIGINE) · Vertex Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.